All Articles

The Cost-Effectiveness of GemCis With or Without Durvalumab in Patients With Advanced CCA
Cholangiocarcinoma
2023 Year in Review - Cholangiocarcinoma
This study examined the costs of treatment with gemcitabine/cisplatin with or without durvalumab in patients with advanced cholangiocarcinoma.
Read More
NUC-1031 Plus Cisplatin Versus GemCis for First-line Treatment of Advanced BTC, NuTide: 121
Cholangiocarcinoma
2023 Year in Review - Cholangiocarcinoma
In the phase 3 Nutide:121 study, NUC-1031 plus cisplatin was compared with gemcitabine/cisplatin for first-line treatment of patients with advanced biliary tract cancer.
Read More
The Most Beautiful Sound
By Kristin Siyahian
Interviews
December 2023 Vol 14, No 12
There’s a sound researchers want your patients to hear—the sound of cancer cells being destroyed.
Read More
Best Practices in Ovarian Function Suppression in Premenopausal Women with HR+ Breast Cancer
Best Practices in Ovarian Function Suppression in Premenopausal Women with HR+ Breast Cancer
By Emily Beard, RN, BSN, OCN, CBCN; Abbey J. Kaler, MS, APRN, FNP-C; Mohammed A. Jaloudi, MD
Ovarian Cancer
Special Issues and Supplements
Invasive breast cancer will be diagnosed in an estimated 300,000 American women in 2023. Early screening and targeted treatment have improved overall survival since the late 1980s, but breast cancer remains the second most common cause of cancer death in women, occurring in 1 in 39 women.
Read More
Oncology Patient Success With Reimbursement, Sustainability, and Job Roles
By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
The Editor’s Take
December 2023 Vol 14, No 12
With the impending reimbursement for navigation services in 2024, the role of navigators is becoming sustainable. That’s a wrap for a banner year in oncology patient navigation for 2023!
Read More
An Introduction to the Science of Compassion
By Katelyn Carey, BSN, RN
Best Practices
December 2023 Vol 14, No 12
The emerging fields of compassion science and trauma-informed care offer insights to improve your navigation practice.
Read More
An Integrative Education Program for Patients With Endometrial and Ovarian Cancer and Their Caregivers: Analyses of Research Article Literature
By Debra Rundles, MSN, RN, OCN, ONN-CG; Emily Gentry, RN, BSN, HON-ONN-CG, OCN
Highlights From AONN+
December 2023 Vol 14, No 12
As part of an AONN+ women’s health initiative, we present findings from a comprehensive search of the published scientific literature for physical, psychological, social, and spiritual well-being of patients diagnosed with endometrial and ovarian cancer and their caregivers.
Read More
Navigating the Antibody– Drug Conjugate Treatment Landscape for Patients With HER2-Positive or HER2-Low Metastatic Breast Cancer
Breast Cancer
December 2023 Vol 14, No 12
Navigating the antibody–drug conjugate treatment landscape for patients with HER2-positive or HER2-low metastatic breast cancer.
Read More
Congratulations to the 2023 CATCH Award Winners!
The CATCH
December 2023 Vol 14, No 12
AONN+ Congratulates the 2023 CATCH Award winners Laura Kaminski and Cynthia Shechter.
Read More
The Enhancing Oncology Model: Furthering Value-Based Care in Cancer
December 2023 Vol 14, No 12
The field of oncology has undergone a significant transformation with the emergence of alternative payment models and a growing emphasis on value-based care.
Read More

Page 31 of 283

Journal of Oncology Navigation & Survivorship

Contact Us | Editorial Board

Amplity

© Amplity, Inc. All rights reserved.

Connect with Us

 
 
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country

Back to Top

Amplity © Amplity, Inc. All rights reserved.